©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 108678
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108678
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108678
Table 1 Overview of the cell types, cytokines with their actions on target cells
| Cytokine | T helper cell type | Target cell | Action | Net effect on plague formation |
| TNF-α | Th1 | Macrophages, endothelial cells | Promotes atherogenesis by increasing the expression of adhesion molecules on endothelial cells, leading to the recruitment of inflammatory cells into the arterial wall | Proatherogenic |
| IFN-γ | Th1 | Macrophages, CD8, T cells, NK cells | Despite its antiviral effects, it increases adhesion molecules expression | Proatherogenic |
| IL-2 | Th1 | T cell | B cell clonal expansion and T cell development | Proatherogenic (less well-established) |
| IL-4 | Th2 | T and B cells | Promotes T cell development, upregulate pro-inflammatory mediators | Antiatherogenic (less well-established) |
| IL-5 | Th2 | B cell | B cell activation and production of protective natural immunoglobulin M antibodies against oxidation-specific antigens | Antiatherogenic (less well-established) |
| IL-6 | Macrophages | Macrophages, Th1 | Increase adhesion molecule expression | Proatherogenic |
| IL-8 | Th2 | Neutrophils | Releasing reactive oxygen species and promoting inflammation | Proatherogenic |
| IL-10 | T reg cell | Macrophages, B cells | Suppresses activation of Th1 cells and macrophages | Antiatherogenic |
- Citation: Elkhattib I, Raafat KW, Elsayed B, Elnaggar M. Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease. World J Hepatol 2025; 17(8): 108678
- URL: https://www.wjgnet.com/1948-5182/full/v17/i8/108678.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i8.108678